Correlation Between Protagonist Therapeutics and Esperion Therapeutics
Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagonist Therapeutics and Esperion Therapeutics, you can compare the effects of market volatilities on Protagonist Therapeutics and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Esperion Therapeutics.
Diversification Opportunities for Protagonist Therapeutics and Esperion Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Protagonist and Esperion is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Esperion Therapeutics go up and down completely randomly.
Pair Corralation between Protagonist Therapeutics and Esperion Therapeutics
Given the investment horizon of 90 days Protagonist Therapeutics is expected to generate 0.59 times more return on investment than Esperion Therapeutics. However, Protagonist Therapeutics is 1.69 times less risky than Esperion Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Esperion Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 2,242 in Protagonist Therapeutics on December 6, 2024 and sell it today you would earn a total of 1,663 from holding Protagonist Therapeutics or generate 74.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagonist Therapeutics vs. Esperion Therapeutics
Performance |
| Timeline |
| Protagonist Therapeutics |
| Esperion Therapeutics |
Protagonist Therapeutics and Esperion Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagonist Therapeutics and Esperion Therapeutics
The main advantage of trading using opposite Protagonist Therapeutics and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
| Esperion Therapeutics vs. Elanco Animal Health | Esperion Therapeutics vs. SIGA Technologies | Esperion Therapeutics vs. ANI Pharmaceuticals | Esperion Therapeutics vs. Phibro Animal Health |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |